GS
TPST icon

Gagnon Securities’s Tempest Therapeutics TPST Stock Holding History

Gagnon Securities’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-15
Closed -$307K – 97
2016
Q3 		$307K Buy
+15
New +$271K 0.13% 76
2016
Q2 		– Sell
-9
Closed -$254K – 96
2016
Q1 		$254K Hold
9
– – 0.12% 73
2015
Q4 		$264K Sell
9
-1
-10% -$33K 0.12% 70
2015
Q3 		$241K Buy
10
+4
+67% +$269K 0.12% 68
2015
Q2 		$514K Sell
6
-1
-14% -$91.6K 0.2% 56
2015
Q1 		$732K Sell
7
-1
-13% -$133K 0.24% 50
2014
Q4 		$1M Sell
8
-14
-64% -$1.03M 0.32% 35
2014
Q3 		$1.07M Hold
22
– – 0.36% 35
2014
Q2 		$592K Hold
22
– – 0.19% 50
2014
Q1 		$565K Buy
+22
New +$624K 0.17% 52

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gagnon Securities's TPST Position: Q4 2016 in Review

Gagnon Securities sold out of Tempest Therapeutics (TPST) in Q4 2016, closing a stake of 15 shares — an estimated $307K sold.

Gagnon Securities first reported a position in TPST in Q1 2014 and held it in 10 quarters. The position peaked at $1.07M in Q3 2014. 84 funds tracked by Wall St. Rank hold TPST as of Q4 2016.

  • Gagnon Securities reported no remaining Tempest Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Gagnon Securities sold 15 Tempest Therapeutics shares in Q4 2016, an estimated $307K.
  • Gagnon Securities first reported a position in Tempest Therapeutics in Q1 2014 and held it in 10 quarters.
  • Gagnon Securities's Tempest Therapeutics position peaked at $1.07M in Q3 2014.
  • 84 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2016.

Based on Gagnon Securities's 13F filing for Q4 2016, filed 14 Feb 2017.